Utilization and Effectiveness of the CA 19-9 Test for Cancer Diagnosis: Insights from Health Ministry Records
-
Published:2023-08-01
Issue:3
Volume:24
Page:322-327
-
ISSN:2619-9793
-
Container-title:Istanbul Medical Journal
-
language:
-
Short-container-title:Istanbul Med J
Author:
Ülgü Mustafa MahirORCID,
Birinci ŞuayipORCID
Publisher
Galenos Yayinevi
Reference10 articles.
1. CA 19-9: biochemical and clinical aspects;Scarà;Adv Exp Med Biol,2015
2. Lamerz R. Role of tumour markers, cytogenetics. Ann Oncol 1999; (10 Suppl): 145-9.
3. Carbohydrate antigen 19-9 elevation without evidence of malignant or pancreatobiliary diseases;Kim;Sci Rep,2020
4. Ardengh JC, Brunaldi VO, Brunaldi MO, Gaspar AF, Lopes-Júnior JR, Sankarankutty AK, et al. Is the new procore 20g double forward-bevel needle capable to obtain better histological samples by endoscopic ultrasound for diagnosing solid pancreatic lesions? Arq Bras Cir Dig 2021; 33: e1554.
5. CA 19-9 tumour-marker response to chemotherapy in patients with advanced pancreatic cancer enrolled in a randomised controlled trial;Hess;Lancet Oncol,2008